{"created":"2023-07-25T10:23:41.074222+00:00","id":3436,"links":{},"metadata":{"_buckets":{"deposit":"7ea56737-d80a-4015-b7d3-7d4c0173c49c"},"_deposit":{"created_by":3,"id":"3436","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"3436"},"status":"published"},"_oai":{"id":"oai:air.repo.nii.ac.jp:00003436","sets":["611:968:969:1171"]},"author_link":["11561"],"item_10006_alternative_title_32":{"attribute_name":"別タイトル","attribute_value_mlt":[{"subitem_alternative_title":"ボスチニブの血漿トラフ値と毒性との関連について:慢性骨髄性白血病患者に対するボスチニブの標と準量投与法と用量漸増法の経験"}]},"item_10006_biblio_info_34":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2019-03-21","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{}]}]},"item_10006_date_granted_41":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2019-03-21"}]},"item_10006_degree_grantor_40":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"秋田大学"}]}]},"item_10006_degree_name_39":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士(医学)"}]},"item_10006_dissertation_number_42":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"11401甲第1300号"}]},"item_10006_publisher_28":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"秋田大学"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"三田, 亜紀子"}],"nameIdentifiers":[{"nameIdentifier":"11561","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-06-17"}],"displaytype":"detail","filename":"ihakuyoushikou1300.pdf","filesize":[{"value":"232.4 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"内容要旨及び審査結果要旨","url":"https://air.repo.nii.ac.jp/record/3436/files/ihakuyoushikou1300.pdf"},"version_id":"813217a7-74f9-4bfd-b0b1-63d6a1641ebd"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"thesis","resourceuri":"http://purl.org/coar/resource_type/c_46ec"}]},"item_title":"Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose‑escalation regimens of bosutinib treatment for patients with chronic myeloid Leukemia","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose‑escalation regimens of bosutinib treatment for patients with chronic myeloid Leukemia"}]},"item_type_id":"10006","owner":"3","path":["1171"],"pubdate":{"attribute_name":"公開日","attribute_value":"2019-06-17"},"publish_date":"2019-06-17","publish_status":"0","recid":"3436","relation_version_is_last":true,"title":["Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose‑escalation regimens of bosutinib treatment for patients with chronic myeloid Leukemia"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2023-07-25T11:20:44.008956+00:00"}